Home » Topics » BioWorld Science

BioWorld Science
RSS

Small molecule WX2-43 targets PRMT5-KLF4 for triple-negative breast cancer treatment

Aug. 6, 2019

Derivatives of Nectandra leucantha neolignans with activity against Trypanosoma cruzi

Aug. 6, 2019

Researchers report findings on distribution studies of ENV-101

Aug. 6, 2019

Adenosine A2A receptor antagonists disclosed by Sichuan Kelun-Biotech Biopharmaceutical

Aug. 6, 2019

Nanjing TransThera Biosciences discloses TRYO3/ AXL/MERTK/CSF-1R inhibitors

Aug. 6, 2019

Vertex Pharmaceuticals patents DNA-dependent protein kinase inhibitors

Aug. 6, 2019

Influenza cap-dependent endonuclease inhibitors described by Ginkgo Pharmaceutical

Aug. 6, 2019

Idorsia Pharmaceuticals discovers IDO-1 and/or TDO inhibitors

Aug. 6, 2019

Positive results from phase II study of SQX-770 in the prevention of herpes labialis

Aug. 6, 2019

Dosing starts in phase I study of DNL-758

Aug. 6, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...